75A50126R00001 NPIVS RFP_PresolNotice.pdf
PDF 160 KB Posted
- Solicitation number
- 75A50126R00001_RFP_PreSolNotice_NPIVS-2027
About this file
This is a Pre-Solicitation Notice for a Vaccine Medical Countermeasures (MCMs) program issued by the Biomedical Advanced Research and Development Authority (BARDA), a division of the Department of Health and Human Services Office of the Assistant Secretary for Preparedness & Response.
BARDA seeks contractor(s) to support the continuation of the Vaccine MCMs for Pandemic Influenza Preparedness and Response Program. Contractors must furnish all necessary services, qualified personnel, materials, supplies, equipment, and U.S. facilities to provide MCMs including vaccines, antigens, and adjuvants for pandemic preparedness and response; produce antigen and vaccines against influenza virus and other viruses with pandemic potential; produce antigens, adjuvants, and/or vaccines to support USG efforts to improve influenza vaccines; and support regulatory decisions and manufacturing readiness by generating and submitting relevant data to the FDA. To be eligible for award, offerors must produce vaccines against influenza and influenza strains with pandemic potential and demonstrate successful manufacturing experience by either holding a U.S. influenza vaccine license or having developed an influenza vaccine evidenced by submission of a Biologics License Application (BLA) for seasonal or pandemic influenza vaccine. This notice is full and open competition under PSC Code AN12 (Health R&D Services) with a size standard of 1,000 employees. Solicitation Number 75A50126R00001 is anticipated to be released in August 2026 through SAM.gov, with an indefinite delivery, indefinite quantity (IDIQ) contract expected to be awarded in or around August 2027. The anticipated period of performance will be 60 months with potential extension to 120 months if all option periods are exercised, and the contract will include both cost reimbursement and firm-fixed price aspects. All respondents must be registered in the System for Award Management (SAM).
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
DEPARTMENT OF HEALTH & HUMAN SERVICES Office of the Secretary Assistant Secretary for Preparedness & Response Washington, D.C. 20201
SAM.GOV
PRESOLICITATION NOTICE
THIS IS A NOTICE OF INTENT, NOT A REQUEST FOR PROPOSAL. A SOLICITATION MAY BE
ISSUED ON A LATER DATE.
Title: Vaccine Medical Countermeasures (MCMs) for Pandemic Influenza Preparedness and Response
General Information
Document Type: Pre-Solicitation Notice
Posted Date: July 30, 2026 Solicitation Number: 75A50126R00001
Set-Aside Status Full and Open Competition
PSC Code AN12-Health R&D Services; Health Care Services; Applied Research
Size Standard Employee Count 1,000
NAICS Code:
541714 Research and Development in Biotechnology (except Nanobiotechnology)
Description
BARDA intends to issue a solicitation for the following:
BARDA seeks Contractor(s) to support the continuation of the Vaccine MCMs for Pandemic Influenza Preparedness and Response Program. Contractors will furnish all the necessary services, qualified personnel, materials, supplies, equipment and facilities (U.S. facilities preferred) not otherwise provided by the USG as needed to provide MCMs, such as vaccines, antigens, and adjuvants, for pandemic preparedness and response or as required in response to a public health emergency; produce antigen and vaccines against influenza virus or other viruses with pandemic potential as required by BARDA; produce antigens, adjuvants, and/or vaccines to support USG efforts to further improve influenza vaccines (for which feasibility data is available); and support rapid regulatory decisions and manufacturing readiness by generating and submitting to FDA all relevant data (e.g., analytical, nonclinical, clinical, and/or chemistry, manufacturing, and controls (CMC)), including data generated during interpandemic periods.
Mandatory Qualification Requirements:
To be eligible for award, the Offeror must produce vaccines against influenza and influenza strains with pandemic potential; must demonstrate a successful experience in the manufacturing of influenza vaccine by:
1. Holding a U.S. influenza vaccine license; or
2. Have developed an influenza vaccine as evidenced by:
a. Submission of a BLA for seasonal or pandemic influenza vaccine
Pre-Solicitation Notice Objective
This Pre-solicitation Notice is issued pursuant to FAR 5.101. It does not constitute a Request for Proposal (RFP) or a promise to issue an RFP in the future. This Pre-solicitation Notice does not commit the Government to contract for any supply or service whatsoever. Furthermore, the Biomedical Advanced Research and Development (BARDA) Division of Contracts Management and Acquisition (CMA) is not at this time seeking proposals and will not accept unsolicited proposals.
It is anticipated that a Request for Proposals (RFP) may be available electronically through the SAM.gov website under Contract Opportunities in August 2026. Once an RFP is posted we encourage all responsible sources, particularly small businesses, to submit a proposal which will be considered by the agency. It is the Offeror's responsibility to monitor this internet site (sam.gov) for the release of this solicitation as well as any amendments. Potential Offerors will be responsible for downloading their own copy of the solicitation and any amendments via this website.
It is anticipated that an indefinite delivery, indefinite quantity (IDIQ) contract with both cost reimbursement and firm-fixed price aspects will be awarded in or around August 2027. The anticipated period of performance for any resultant contract(s) will be for a total of 60 months and up to 120 months, if all Option periods are exercised. Additional details and requirements will be described in the solicitation.
Furthermore, all respondents must be registered in the System for Award Management (SAM):
https://www.sam.gov.
Contracting Office Address:
Office of the Assistant Secretary for Preparedness & Response (ASPR) Center for the Biomedical Advanced Research and Development Authority (BARDA) Department of Health and Human Services (HHS) 400 7th Street SW Washington, District of Columbia 20024 United States
Points of Contact:
Laura Saddison BARDA Contracting Officer Laura.Saddison@hhs.gov
File details come from the government source that posted it. Updated .